News2022-09-12T16:29:50-05:00
September 12th, 2024|

DOJ Criminal Division Officially Launches Corporate Whistleblower Awards Pilot Program

Earlier this year, Deputy AG Lisa Monaco announced that the U.S. Department of Justice (DOJ) was launching a pilot program that would financially reward whistleblowers who report significant corporate misconduct. The Pilot Program is aimed to incentivize the reporting of misconduct in areas that have not historically been covered under [...]

Baron & Budd Investigating Medicare and Medicaid Fraud in Patient Assistance Programs for Specialty Drugs

September 24th, 2018|

Whistleblowers play key role highlighting fraudulent charities that target public insurance programs September 24, 2018 WASHINGTON -- Today, the national law firm Baron & Budd [...]

Baron & Budd Secures $110 Million to Settle Texas Whistleblower Lawsuits Against AstraZeneca for Fraudulently Marketing Seroquel, Crestor

August 8th, 2018|

Suits Alleged Pharmaceutical Giant Illegally Promoted Seroquel Prescriptions for Children, Misrepresented Safety of Crestor August 07, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced [...]

Baron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved Uses

August 8th, 2018|

Pharmaceutical Company Allegedly Violated Federal and Texas Medicaid Laws August 01, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced that Endo Pharmaceuticals Inc. (“Endo”) [...]

Baron & Budd Secures Three Additional Settlements with Virginia Defense Contractors for Alleged FCA Violations Totaling $620,000

March 26th, 2018|

Washington, D.C. - The national law firm of Baron & Budd today announced that the U.S. Department of Justice has reached settlements with three additional [...]

Go to Top